Avricore Health Inc. (TSE:AVCR)
:AVCR
Want to see TSE:AVCR full AI Analyst Report?
AVCR Stock Chart & Stats
C$0.05
>-C$0.01(-8.33%)
At close: 4:00 PM EST
C$0.05
>-C$0.01(-8.33%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.10
Previous CloseN/A
Volume23.00K
Average Volume (3M)51.37K
Market Cap
C$6.08M
Enterprise ValueC$5.85M
Total Cash (Recent Filing)C$237.92K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta1.04
Next Earnings
May 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding101,289,665
10 Day Avg. Volume29,762
30 Day Avg. Volume51,367
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)13.00
Price to Sales (P/S)9.49
P/FCF Ratio-5.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetMinimal leverage reduces solvency and refinancing risk over the medium term, giving management flexibility to fund operations or strategic pushes without heavy interest burdens. For a company with volatile cash flow, low debt materially lowers probability of distress and preserves optionality.
Improving Unit EconomicsRising gross margins show the core POCT services and HealthTab platform achieved better unit economics through 2024, indicating operational leverage potential. Sustained higher gross margins support future profitability if revenue base stabilizes and SG&A growth is controlled.
Recurring, Platform-Based Revenue ModelA mix of recurring platform fees and per-test service revenues creates diversified, repeatable cash flow when pharmacy site counts and volumes scale. Structural pharmacy partnerships and software-driven reporting increase stickiness and potential for upsell and program expansion.
Bears Say
Sharp 2025 Revenue ContractionA pronounced revenue collapse in 2025 undermines the durability of prior growth and raises questions about customer retention, program demand, or contract continuity. Persistent top-line volatility makes forecasting cash flow and achieving scale economics materially harder over the medium term.
Return To Cash BurnReverting to negative operating and free cash flow erodes liquidity and forces reliance on external capital if losses persist. For a small firm, repeated cash burn cycles limit runway for commercialization, slow platform investments, and increase dilution risk from future financings.
Earnings And Equity PressureSizable losses that reduce equity indicate ongoing value dilution and weak profitability conversion. Deeply negative returns on equity signal the business is not currently generating shareholder value, constraining ability to build reserves or fund growth from internal cash.
Avricore Health News
AVCR FAQ
What was Avricore Health Inc.’s price range in the past 12 months?
Avricore Health Inc. lowest stock price was C$0.04 and its highest was C$0.10 in the past 12 months.
What is Avricore Health Inc.’s market cap?
Avricore Health Inc.’s market cap is C$6.08M.
When is Avricore Health Inc.’s upcoming earnings report date?
Avricore Health Inc.’s upcoming earnings report date is May 28, 2026 which is in 4 days.
How were Avricore Health Inc.’s earnings last quarter?
Currently, no data Available
Is Avricore Health Inc. overvalued?
According to Wall Street analysts Avricore Health Inc.’s price is currently Overvalued.
Does Avricore Health Inc. pay dividends?
Avricore Health Inc. does not currently pay dividends.
What is Avricore Health Inc.’s EPS estimate?
Avricore Health Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avricore Health Inc. have?
Avricore Health Inc. has 101,289,665 shares outstanding.
What happened to Avricore Health Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Avricore Health Inc.?
Currently, no hedge funds are holding shares in TSE:AVCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Avricore Health Inc.
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a lab-accurate point of care testing platform for pharmacy. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Technical Analysis
BioMark Diagnostics
―
Telo Genomics Corp
―
StageZero Life Sciences Ltd
―
―
PanGenomic Health, Inc. Class A
―
Options Prices
Currently, No data available
---